David Harrich

5.4k total citations · 2 hit papers
87 papers, 4.5k citations indexed

About

David Harrich is a scholar working on Virology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, David Harrich has authored 87 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 58 papers in Virology, 43 papers in Infectious Diseases and 38 papers in Molecular Biology. Recurrent topics in David Harrich's work include HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (31 papers) and Virus-based gene therapy research (11 papers). David Harrich is often cited by papers focused on HIV Research and Treatment (58 papers), HIV/AIDS drug development and treatment (31 papers) and Virus-based gene therapy research (11 papers). David Harrich collaborates with scholars based in Australia, United States and China. David Harrich's co-authors include Richard B. Gaynor, F Wu, Haran Sivakumaran, Ronald T. Mitsuyasu, Joseph A. Garcia, S.-H.I. Ou, León F. Garcı́a-Martı́nez, David A. Jans, Kylie M. Wagstaff and Steven M. Heaton and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and SHILAP Revista de lepidopterología.

In The Last Decade

David Harrich

87 papers receiving 4.4k citations

Hit Papers

Cloning and characterization of a novel cellular protein,... 1995 2026 2005 2015 1995 2012 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs
    1995 607 citations F Wu, David Harrich et al. Journal of Virology profile →
  2. Ivermectin is a specific inhibitor of importin α/β-mediated nuclear import able to inhibit replication of HIV-1 and dengue virus
    2012 523 citations Haran Sivakumaran, David Harrich et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Harrich Australia 34 2.0k 1.9k 1.4k 868 638 87 4.5k
Craig B. Wilen United States 34 3.4k 1.7× 794 0.4× 2.0k 1.5× 1.0k 1.2× 710 1.1× 66 6.1k
Bharat Ramratnam United States 34 1.6k 0.8× 2.5k 1.3× 2.0k 1.5× 1.1k 1.2× 703 1.1× 73 4.9k
Kohji Moriishi Japan 41 2.4k 1.2× 342 0.2× 968 0.7× 949 1.1× 1.8k 2.8× 145 5.8k
Paul Bates United States 42 1.7k 0.8× 982 0.5× 3.4k 2.5× 1.3k 1.5× 2.0k 3.1× 66 6.4k
Roger Le Grand France 46 1.4k 0.7× 2.7k 1.4× 2.8k 2.0× 2.8k 3.3× 1.6k 2.5× 283 7.7k
Kenzo Tokunaga Japan 29 1.3k 0.6× 1.6k 0.8× 1.5k 1.1× 1.0k 1.2× 724 1.1× 86 3.5k
Jacqueline D. Reeves United States 31 883 0.4× 2.9k 1.5× 2.9k 2.1× 1.8k 2.0× 1.1k 1.6× 62 5.2k
Murray B. Gardner United States 38 1.8k 0.9× 2.5k 1.3× 1.0k 0.8× 1.8k 2.1× 1.7k 2.6× 135 6.2k
Fatah Kashanchi United States 59 6.1k 3.0× 3.2k 1.7× 2.4k 1.7× 3.0k 3.4× 1.2k 1.9× 257 10.6k
Xiaodong Xiao United States 31 1.1k 0.6× 862 0.4× 1.2k 0.9× 911 1.0× 426 0.7× 62 3.3k

Countries citing papers authored by David Harrich

Since Specialization
Citations

This map shows the geographic impact of David Harrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Harrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Harrich more than expected).

Fields of papers citing papers by David Harrich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Harrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Harrich. The network helps show where David Harrich may publish in the future.

Co-authorship network of co-authors of David Harrich

This figure shows the co-authorship network connecting the top 25 collaborators of David Harrich. A scholar is included among the top collaborators of David Harrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Harrich. David Harrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Qu, Zhi, Vinod Kumar, Youzhi Wu, et al.. (2024). Novel Delivery Systems for Oral Administration of Enfuvirtide: New Treatment Options for HIV/AIDS. Advanced Therapeutics. 7(8). 2 indexed citations
2.
Harris, Richard J., Nicholas J. Youngman, Christina N. Zdenek, et al.. (2020). Assessing the Binding of Venoms from Aquatic Elapids to the Nicotinic Acetylcholine Receptor Orthosteric Site of Different Prey Models. International Journal of Molecular Sciences. 21(19). 7377–7377. 18 indexed citations
3.
Harris, Richard J., Christina N. Zdenek, David Harrich, Nathaniel Frank, & Bryan G. Fry. (2020). An Appetite for Destruction: Detecting Prey-Selective Binding of α-Neurotoxins in the Venom of Afro-Asian Elapids. Toxins. 12(3). 205–205. 41 indexed citations
4.
Harris, Richard J., Christina N. Zdenek, Jordan Debono, David Harrich, & Bryan G. Fry. (2020). Evolutionary Interpretations of Nicotinic Acetylcholine Receptor Targeting Venom Effects by a Clade of Asian Viperidae Snakes. Neurotoxicity Research. 38(2). 312–318. 23 indexed citations
5.
Zdenek, Christina N., Richard J. Harris, Sanjaya Kuruppu, et al.. (2019). A Taxon-Specific and High-Throughput Method for Measuring Ligand Binding to Nicotinic Acetylcholine Receptors. Toxins. 11(10). 600–600. 34 indexed citations
6.
7.
Li, Dongsheng, Ting Wei, Mary Lor, et al.. (2018). The eukaryotic translation elongation factor 1A regulation of actin stress fibers is important for infectious RSV production. Virology Journal. 15(1). 182–182. 12 indexed citations
8.
Fulcher, Alex J., et al.. (2015). The protein arginine methyltransferase PRMT6 inhibits HIV-1 Tat nucleolar retention. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1863(2). 254–262. 16 indexed citations
9.
Apolloni, Ann, Min‐Hsuan Lin, Haran Sivakumaran, et al.. (2013). A Mutant Tat Protein Provides Strong Protection from HIV-1 Infection in Human CD4 + T Cells. Human Gene Therapy. 24(3). 270–282. 18 indexed citations
10.
Dang, Nhung, Haran Sivakumaran, David Harrich, & Allan G.A. Coombes. (2013). An Evaluation of Polycaprolactone Matrices for Vaginal Delivery of the Antiviral, Tenofovir, in Preventing Heterosexual Transmission of HIV. Journal of Pharmaceutical Sciences. 102(10). 3725–3735. 12 indexed citations
11.
Warrilow, David, Deborah Stenzel, & David Harrich. (2007). Isolated HIV-1 core is active for reverse transcription. SHILAP Revista de lepidopterología. 28 indexed citations
12.
Warrilow, David, Luke W. Meredith, Adam Davis, et al.. (2007). Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro. Journal of Virology. 82(3). 1425–1437. 37 indexed citations
13.
Warrilow, David, Joy Gardner, Grant A. Darnell, Andreas Suhrbier, & David Harrich. (2006). HIV Type 1 Inhibition by Protein Kinase C Modulatory Compounds. AIDS Research and Human Retroviruses. 22(9). 854–864. 52 indexed citations
14.
Harrich, David, Nigel A.J. McMillan, Liliana Endo‐Munoz, Ann Apolloni, & Luke W. Meredith. (2006). Will Diverse Tat Interactions Lead to Novel Antiretroviral Drug Targets?. Current Drug Targets. 7(12). 1595–1606. 14 indexed citations
15.
Darnell, Grant A., Toni Antalis, Ricky W. Johnstone, et al.. (2003). Inhibition of Retinoblastoma Protein Degradation by Interaction with the Serpin Plasminogen Activator Inhibitor 2 via a Novel Consensus Motif. Molecular and Cellular Biology. 23(18). 6520–6532. 63 indexed citations
16.
Harvey, Tracey J., Itaru Anraku, Richard Linedale, et al.. (2003). Kunjin Virus Replicon Vectors for Human Immunodeficiency Virus Vaccine Development. Journal of Virology. 77(14). 7796–7803. 45 indexed citations
17.
Hooker, C. William, et al.. (2002). Human Immunodeficiency Virus Type 1 Reverse Transcription Is Stimulated by Tat from Other Lentiviruses. Virology. 300(2). 226–235. 9 indexed citations
18.
Harrich, David. (1997). Tat is required for efficient HIV-1 reverse transcription. The EMBO Journal. 16(6). 1224–1235. 130 indexed citations
19.
20.
Wu, F, José Ángel García, David Harrich, & Richard B. Gaynor. (1988). Purification of the human immunodeficiency virus type 1 enhancer and TAR binding proteins EBP-1 and UBP-1.. The EMBO Journal. 7(7). 2117–2130. 187 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Craig B. Wilen Breakdown of academic impact, for papers by Bharat Ramratnam Breakdown of academic impact, for papers by Kohji Moriishi Breakdown of academic impact, for papers by Paul Bates Breakdown of academic impact, for papers by Roger Le Grand Breakdown of academic impact, for papers by Kenzo Tokunaga Breakdown of academic impact, for papers by Jacqueline D. Reeves Breakdown of academic impact, for papers by Murray B. Gardner Breakdown of academic impact, for papers by Fatah Kashanchi Breakdown of academic impact, for papers by Xiaodong Xiao
Rankless by CCL
2026